Redmond Asset Management LLC Buys 3,456 Shares of Becton, Dickinson and Company (NYSE:BDX)

Redmond Asset Management LLC boosted its stake in Becton, Dickinson and Company (NYSE:BDX) by 115.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 6,453 shares of the medical instruments supplier’s stock after purchasing an additional 3,456 shares during the quarter. Redmond Asset Management LLC’s holdings in Becton, Dickinson and Company were worth $1,464,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Bank of Jackson Hole Trust bought a new stake in Becton, Dickinson and Company in the fourth quarter valued at $25,000. Sierra Ocean LLC bought a new position in shares of Becton, Dickinson and Company in the 4th quarter worth about $29,000. Ashton Thomas Securities LLC bought a new position in shares of Becton, Dickinson and Company in the 3rd quarter worth about $33,000. Tompkins Financial Corp increased its stake in shares of Becton, Dickinson and Company by 44.2% in the 3rd quarter. Tompkins Financial Corp now owns 150 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 46 shares in the last quarter. Finally, Kennebec Savings Bank bought a new position in shares of Becton, Dickinson and Company in the 3rd quarter worth about $46,000. Institutional investors own 86.97% of the company’s stock.

Insider Buying and Selling

In other Becton, Dickinson and Company news, EVP Shana Carol Neal sold 788 shares of Becton, Dickinson and Company stock in a transaction that occurred on Tuesday, January 7th. The shares were sold at an average price of $235.00, for a total transaction of $185,180.00. Following the transaction, the executive vice president now owns 16,201 shares of the company’s stock, valued at $3,807,235. The trade was a 4.64 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Roland Goette sold 638 shares of Becton, Dickinson and Company stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $219.03, for a total transaction of $139,741.14. Following the sale, the executive vice president now owns 14,217 shares in the company, valued at approximately $3,113,949.51. The trade was a 4.29 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 10,544 shares of company stock valued at $2,370,309. 0.36% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on BDX. StockNews.com upgraded shares of Becton, Dickinson and Company from a “hold” rating to a “buy” rating in a research note on Wednesday, February 12th. Piper Sandler increased their price target on shares of Becton, Dickinson and Company from $275.00 to $280.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 28th. Finally, Barclays increased their price target on shares of Becton, Dickinson and Company from $278.00 to $279.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. Eight equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $278.29.

Becton, Dickinson and Company Stock Performance

Shares of BDX stock opened at $227.54 on Friday. The company has a 50 day moving average price of $232.90 and a 200-day moving average price of $233.29. Becton, Dickinson and Company has a 52 week low of $218.75 and a 52 week high of $251.99. The firm has a market capitalization of $65.34 billion, a PE ratio of 37.80, a P/E/G ratio of 1.63 and a beta of 0.40. The company has a quick ratio of 0.63, a current ratio of 1.13 and a debt-to-equity ratio of 0.69.

Becton, Dickinson and Company (NYSE:BDX) last announced its quarterly earnings results on Wednesday, February 5th. The medical instruments supplier reported $3.43 EPS for the quarter, topping analysts’ consensus estimates of $3.00 by $0.43. Becton, Dickinson and Company had a net margin of 8.47% and a return on equity of 15.74%. As a group, equities research analysts expect that Becton, Dickinson and Company will post 14.43 earnings per share for the current year.

Becton, Dickinson and Company announced that its Board of Directors has authorized a stock repurchase program on Tuesday, January 28th that allows the company to repurchase 10,000,000 outstanding shares. This repurchase authorization allows the medical instruments supplier to reacquire shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board believes its stock is undervalued.

Becton, Dickinson and Company Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 10th will be issued a $1.04 dividend. This represents a $4.16 dividend on an annualized basis and a dividend yield of 1.83%. The ex-dividend date is Monday, March 10th. Becton, Dickinson and Company’s payout ratio is 69.10%.

Becton, Dickinson and Company Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.